GREENSBORO, N.C., Dec. 18, 2012 (GLOBE NEWSWIRE) -- Prophecy Healthcare® (www.ProphecyHealthcare.com), the nation's leading provider of clinical assessment service in the healthcare industry, announced a partnership with TestingColorVision.com (TCV) to provide a cutting edge color vision assessment that is the most comprehensive on the market to date. Undetected color vision deficiencies put patients' lives at risk. This new partnership continues to place patient safety at the forefront of Prophecy's corporate philosophy – offering holistic assessment products to facilities and agencies to ensure quality patient care at the bedside.
"When evaluating assessments to add to our clinical exam library, we strive to raise the industry standard to a new level. TCV's color vision assessment does just that by not only detecting deficiencies, but also offering over 100 HD test plates to round out a true diagnostic readout," said Ron Gonzalez, Founder and CEO of Prophecy Healthcare®. "We feel confident that the Waggoner Color Vision Test raises the level of care possible for healthcare providers with CVDs, ultimately translating to increasing patient safety."
Nearly 8-12% of males and .5% of females are effected by color vision deficiencies (CVD). What is more alarming is that 20-30% of people with a CVD are unaware they have the condition!
Color vision plays an important factor in bedside care. Here are just a few situations where being unaware of a healthcare employee's CVD puts patients' safety at risk:
- Stages of bruising (1st: purple/black, 2nd: green/yellow)
- Interpreting cardiac monitors
- Selecting color coded phlebotomy tubes, medications, charts, slides, and prints
- Reading Ultrasound Doppler color images
For more information on The Truth About Color Vision, we invite you to download this whitepaper co-authored by Terrace L. Waggoner Jr. (T.J.), MBA, MA and Dr. Terrace L. Waggoner Sr., O.D., the developers of the Waggoner Color Vision Test being offered via Prophecy Healthcare's assessment solutions. "We are very excited to be partnering with an organization that is using technology to transform healthcare. We know that Prophecy Health is already making healthcare a safer place for patients and we're excited to be able to strengthen their commitment to safety by providing an effective and efficient color vision test. Only great things will come from the relationship between TCV and Prophecy," said Terrace L. Waggoner Jr., Co-Founder and CEO of TestingColorVision.com.
About Prophecy Healthcare®
Originally founded in 2004 as NurseTesting.com, Prophecy Healthcare got its start as the first online Pre-Employment Testing Company exclusive to the Healthcare Industry. Initially focusing solely on clinical assessments measuring clinical competencies, efforts to exceed industry expectations led to isolating critical competencies missed in traditional testing initiatives, such as stress tolerance, critical thinking, and teamwork skills. The Prophecy approach offers the ability to find candidates with the clinical hard skills, personality attributes, and desired soft skills to match each organization. For more information about Prophecy, visit http://www.prophecyhealth.com or call 336.802.1070.
About TestingColorVision.com
Dr. Terrace L. Waggoner Sr., an optometrist and color vision expert for the U.S. military, and his son, Terrace L. Waggoner Jr. (T.J.), founded TestingColorVision.com in 2009. With Dr. Waggoner's knowledge about color vision and T.J.'s educational background, an MBA and MA of Industrial/Organization Psychology, they sought to create a groundbreaking new color vision test. T.J. has a color vision deficiency and was able to help Dr. Waggoner create a test that would be difficult to cheat on, unlike the common Ishihara. TCV began only testing for CVDs, but is beginning to consult with the healthcare industry on color vision and creating a safer environment for patients. For more information about TCV, visit http://www.TestingColorVision.com or call 850.288.1246.
Photos accompanying this release are available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=16335
